Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Lung|March 20, 2019
Nutritional Status in Childhood as a Prognostic Factor in Patients with Cystic FibrosisMoshe Ashkenazi, N Nathan, I Sarouk, et al.Journal of Medicinal Chemistry|June 27, 2022
Antimicrobial Peptides against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis PatientsDaniel Ben Hur, Gal Kapach, Naiem Ahmad Wani, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2019
Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infectionLea Bentur, Michal Gur, Moshe Ashkenazi, et al.Journal of Pediatric Gastroenterology and Nutrition|October 19, 2018
Resting Energy Expenditure in Patients With Familial Dysautonomia: A Preliminary StudyBat-El Bar Aluma, Lucy Norcliffe-Kaufmann, Ifat Sarouk, et al.Journal of Asthma and Allergy|June 29, 2018
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosisMoshe Ashkenazi, Saray Sity, Ifat Sarouk, et al.Respiratory Care|July 19, 2018
The Value of Measuring Inspiratory Capacity in Subjects With Cystic FibrosisDaphna Vilozni, Adi Dagan, Moran Lavie, et al.Annals of the American Thoracic Society|May 25, 2016
Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic FibrosisDaphna Vilozni, Moran Lavie, Miryam Ofek, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 5, 2024
Clinical efficacy of CFTR modulator therapy in people with cystic fibrosis carrying the I1234V mutationBat El Bar Aluma, Joel Reiter, Ori Efrati, et al.Respiratory Medicine|August 27, 2020
Phenotypic and molecular characteristics of CF patients carrying the I1234V mutationBat El Bar Aluma, Ifat Sarouk, Hanoch Senderowitz, et al.Respiratory Medicine|September 27, 2017
Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experienceAdi Dagan, Malena Cohen-Cymberknoh, Michal Shteinberg, et al.Pageof 3